These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3484967)

  • 41. Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers.
    Wolzt M; Levi M; Sarich TC; Boström SL; Eriksson UG; Eriksson-Lepkowska M; Svensson M; Weitz JI; Elg M; Wåhlander K
    Thromb Haemost; 2004 Jun; 91(6):1090-6. PubMed ID: 15175794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.
    Doñate F; Kelly CR; Ruf W; Edgington TS
    Biochemistry; 2000 Sep; 39(37):11467-76. PubMed ID: 10985793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppression of plasma-activated factor VII levels by warfarin therapy.
    Sakata T; Kario K; Matsuo T; Katayama Y; Matsuyama T; Kato H; Miyata T
    Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):241-6. PubMed ID: 7749832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis.
    Ghaddar HM; Folsom AR; Aleksic N; Hearne LB; Chambless LE; Morrissey JH; Wu KK
    Circulation; 1998 Dec 22-29; 98(25):2815-21. PubMed ID: 9860781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on coagulation and fibrinolysis in pregnancy, with special reference to cold activation of factor VII.
    Gjonnaess H; Fagerhol MK
    Acta Obstet Gynecol Scand; 1975; 54(4):363-7. PubMed ID: 1081809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monitoring of hemostatic status in four patients being treated with recombinant factor VIIa.
    Carr ME; Martin EJ; Kuhn JG; Ambrose H; Fern S; Bryant PC
    Clin Lab; 2004; 50(9-10):529-38. PubMed ID: 15481628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of action of recombinant activated factor VII: an update.
    Hedner U
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S105-7. PubMed ID: 16427375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Positive feedback loops for factor V and factor VII activation supply sensitivity to local surface tissue factor density during blood coagulation.
    Balandina AN; Shibeko AM; Kireev DA; Novikova AA; Shmirev II; Panteleev MA; Ataullakhanov FI
    Biophys J; 2011 Oct; 101(8):1816-24. PubMed ID: 22004734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Occurrence of cold activation of transfusion plasma during storage at +4 degrees C.
    Suontaka AM; Silveira A; Söderström T; Blombäck M
    Vox Sang; 2005 Apr; 88(3):172-80. PubMed ID: 15787727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A longitudinal study of the factor VII rise during pregnancy.
    Wright D; Poller L; Thomson JM; Sidebotham A; Hirst CF; Hirsch P
    Thromb Haemost; 1998 Feb; 79(2):328-30. PubMed ID: 9493585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlative analysis of nanoparticle tracking, flow cytometric and functional measurements for circulating microvesicles in normal subjects.
    Enjeti AK; Ariyarajah A; D'Crus A; Seldon M; Lincz LF
    Thromb Res; 2016 Sep; 145():18-23. PubMed ID: 27429418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.
    Ravanat C; Archipoff G; Beretz A; Freund G; Cazenave JP; Freyssinet JM
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):7-13. PubMed ID: 1311563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
    Bröijersén A; Hamsten A; Silveira A; Fatah K; Goodall AH; Eriksson M; Angelin B; Hjemdahl P
    Thromb Haemost; 1996 Aug; 76(2):171-6. PubMed ID: 8865525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood.
    Gerotziafas GT; Depasse F; Chakroun T; Samama MM; Elalamy I
    Thromb Haemost; 2004 Mar; 91(3):531-7. PubMed ID: 14983229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The increased rate of activation of factor XII in late pregnancy can contribute to the increased reactivity of factor VII.
    Mitropoulos KA; Martin JC; Burgess AI; Esnouf MP; Stirling Y; Howarth DJ; Reeves BE
    Thromb Haemost; 1990 Jun; 63(3):349-55. PubMed ID: 2402739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII.
    Radcliffe R; Nemerson Y
    J Biol Chem; 1975 Jan; 250(2):388-95. PubMed ID: 234427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients.
    Irish AB; Green FR
    Nephrol Dial Transplant; 1997 Jan; 12(1):167-73. PubMed ID: 9027794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of factor VII genotype with plasma factor VII activity and antigen levels in healthy Indian adults and interaction with triglycerides.
    Saha N; Liu Y; Heng CK; Hong S; Low PS; Tay JS
    Arterioscler Thromb; 1994 Dec; 14(12):1923-7. PubMed ID: 7981180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin.
    Bode C; Hudelmayer M; Mehwald P; Bauer S; Freitag M; von Hodenberg E; Newell JB; Kübler W; Haber E; Runge MS
    Circulation; 1994 Oct; 90(4):1956-63. PubMed ID: 7923685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.